Elanco Animal Health (ELAN)
(Delayed Data from NYSE)
$12.93 USD
-0.02 (-0.15%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $12.94 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ELAN 12.93 -0.02(-0.15%)
Will ELAN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ELAN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELAN
Here's What Key Metrics Tell Us About Elanco Animal Health Incorporated (ELAN) Q4 Earnings
Analysts Estimate U.S. Physical Therapy (USPH) to Report a Decline in Earnings: What to Look Out for
ELAN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Elanco Animal Health Incorporated (ELAN) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Other News for ELAN
Jefferies cuts Zoetis target, says vet survey positive for Librela
Notable Two Hundred Day Moving Average Cross - ELAN
Why Lantheus Holdings Inc's Stock Skyrocketed 11% in a Quarter
Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
Elanco Animal Health Larger Than S&P 500 Component Comerica